Global Drug Delivery Devices Market will be worth USD 1,625.1 billion by 2022 – New market report by Data Bridge Market Research

Global Drug Delivery Devices Market is expected to grow at 8.0% in the forecast period 2016 to 2022
Global Drug Delivery Devices Market, By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel, By Geography – Trends and Forecast to 2022

Global Drug Delivery Devices Market, By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

Global drug delivery devices market is expected to reach USD 1,625.1 billion by 2022, from USD 950.0 billion in 2015 growing at a CAGR of 8.0% during the forecast period of 2016 to 2022.

Drug delivery is a process of introducing a therapeutic effect in the human body by administering a pharmaceutical drug at a specific targeted site. Drug delivery system improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. The drug delivery market is segmented on the basis of route of administration, end users, and region.

For Sample Report:

http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market

The global molecular spectroscopy market is segmented based on product type, distribution, end-user and geography.

Based on product type the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is segmented into solid drug, semi-solid drug and liquid drug. The Injectable drug delivery segment is further segmented into devices and formulations. Pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. Topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others.    

Based on end-users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.

 

On the basis of distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.

To read more about the scope and findings of this report visit: 

http://databridgemarketresearch.com/drug-delivery-devices-market-poised-grow-8-0/

Based on geography, the market report covers data 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. U.S. is expected to dominate the market due to rising prevalence of chronic diseases, large healthcare expenditure, and paradigm shift towards value based reimbursements. The reports of this market further segmented into countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.

Major players operating in the global drug delivery devices market are Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc. among others.

To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market

  

Table of Content:

1. INTRODUCTION

   1.1. OVERVIEW OF THE DRUG DELIVERY DEVICES MARKET

   1.2. CURRENCY AND PRICING

   1.3. LIMITATION

   1.4. MARKETS COVERED

2. RESEARCH METHODOLOGY

    2.1. MARKETS IN DRUG DELIVERY DEVICES MARKET

    2.2. GEOGRAPHICAL SCOPE

    2.3. YEARS CONSIDERED IN THE STUDY

    2.4. CURRENCY AND PRICING

    2.5. RESEARCH METHODOLOGY

          2.5.1. MARKET CRACKDOWN APPROACH

          2.5.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

          2.5.3. DATA TRIANGULATION

    2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

    2.7. SECONDARY SOURCES

    2.8. ASSUMPTIONS

3. MARKET OVERVIEW

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

   6.1. OVERVIEW

   6.2. ORAL DRUG DELIVERY, BY FORM

         6.2.1. SOLID ORAL DRUGS, BY PRODUCT TYPE

                  6.2.2.1. TABLETS

                  6.2.2.2. CAPSULES

                  6.2.2.3. POWDER

                  6.2.2.4. PILLS

         6.2.2. LIQUID ORAL DRUGS, BY PRODUCT TYPE

                 6.2.2.1. SOLUTIONS

                 6.2.2.2. SYRUPS

         6.2.3. SEMI SOLID ORAL DRUGS, BY PRODUCT TYPE

                 6.2.3.1. GELS

                 6.2.3.2. EMULSIONS

                 6.2.3.3. ELIXIRS

   6.3. PULMONARY DRUG DELIVERY, BY PRODUCT TYPE

         6.3.1. METERED DOSE INHALERS (MDI)

         6.3.2. DRY POWDER INHALERS (DPI)

         6.3.3. NEBULIZERS

                 6.3.3.1. JET NEBULIZERS

                 6.3.3.2. ULTRASONIC NEBULIZERS

                 6.3.3.3. SOFT MIST NEBULIZERS

   6.4. INJECTABLE DRUG DELIVERY, BY PRODUCT TYPE

         6.4.1. INJECTABLE DRUG DELIVERY DEVICES, BY PRODUCT TYPE

                 6.4.1.1. CONVENTIONALS INJECTABLES, BY MATERIAL

                            6.4.1.1.1. GLASS

                            6.4.1.1.2. PLASTIC

                 6.4.2.2. CONVENTIONALS INJECTABLES, BY PRODUCT TYPE

                            6.4.2.2.1.  FILLABLE

                            6.4.2.2.2.  PRE-FILLED

                 6.4.3.3. CONVENTIONALS INJECTABLES, BY USABILITY

                            6.4.3.3.1. REUSABLE SYRIGES

                            6.4.3.3.2. DISPOSABLE SYRINGES

                 6.4.3.4. SELF INJECTION DEVICES

                 6.4.3.5. NEEDLE FREE INJECTORS

                 6.4.3.6. AUTOINJECTORS

                 6.4.3.7. PEN INJECTORS

                 6.4.3.8. WEARABLE INJCTORS

                 6.4.3.9. OTHERS

         6.4.2. INJECTABLE DRUG DELIVERY FORMULATIONS, BY PRODUCT TYPE

                 6.4.2.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS

                 6.4.2.2. NOVEL DRUG DELIVERY FORMULATIONS

                 6.4.2.3. LONG ACTING INJECTION FORMULATIONS

   6.5. OPTHALMIC DRUG DELIVERY, BY PRODUCT TYPE

         6.5.1. OCCULAR DRUG DELIVERY DEVICES, BY PRODUCT TYPE

                 6.5.1.1. DRUG COATED CONTACT LENSES

                 6.5.1.2. OCCULAR INSERTS

         6.5.2. OCCULAR DRUG DELIVERY FORMULATIONS, BY FORM

                 6.5.2.1. LIQUID OCCULAR DRUG DELIVERY FORMULATIONS, BY TYPE

                            6.5.2.1.1. EYE DROPS

                            6.5.2.1.2. SPRAYS

                 6.5.2.2. SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS, BY TYPE

                            6.5.2.2.1.  GELS

                            6.5.2.2.2.  OINTMENTS

   6.6. NASAL DRUG DELIVERY, BY PRODUCT TYPE

         6.6.1. NASAL DROPS

         6.6.2. NASAL SPRAYS

         6.6.3. NASAL POWDERS

         6.6.4. NASAL GELS

   6.7. TOPICAL DRUG DELIVERY, BY PRODUCT TYPE

         6.7.1. TRANSDERMAL DRUG DELIVERY DEVICES, BY PRODUCT TYPE

                  6.7.1.1. TRANSDERMAL PATCHES

                  6.7.1.2. TRANSDERMAL GELS

         6.7.2. TOPICAL DRUG DELIVERY FORMULATIONS, BY FORM

                  6.7.2.1. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

                             6.7.2.1.1. SOLUTIONS

                             6.7.2.1.2. SUSPENSIONS

                  6.7.2.2. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

                             6.7.2.2.1. GELS

                             6.7.2.2.2.  CREAMS

                             6.7.2.2.3.  OINTMENTS

                             6.7.2.2.4.  PASTES

                             6.7.2.2.5.  LOTIONS

                 6.7.2.3.  SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

                             6.7.2.3.1.  SUPPOSITORIES

                             6.7.2.3.2.  POWDERS

   6.8. IMPLANTABLE DRUG DELIVERY, BY PRODUCT TYPE

         6.8.1. ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES

         6.8.2. PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES

   6.9. TRANSMUCOSAL DRUG DELIVERY, BY PRODUCT TYPE

         6.9.1. ORAL TRANSMUCOSAL DRUG DELIVERY, BY TYPE

                 6.9.1.1. BUCCAL DRUG DELIVERY

                 6.9.1.2. SUBLINGUAL DRUG DELIVERY

         6.9.2. OTHER TRANSMUCOSAL DRUG DELIVERY, BY TYPE

                  6.9.2.1. RECTAL TRANSMUCOSAL DRUG DELIVERY

                  6.9.2.2. TRANSMUCOSAL TRANSMUCOSAL DRUG DELIVERY

7. DRUG DELIVERY DEVICES MARKET, BY END-USER

    7.1. OVERVIEW

    7.2. HOSPITALS

    7.3. HOME HEALTHCARE

    7.4. CLINICS

    7.5. COMMUNITY HEALTHCARE

    7.6. OTHERS

8. DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

   8.1. OVERVIEW

   8.2. HOSPITAL PHARMACIES

   8.3. PHARMACY STORES

   8.4. DIRECT TENDERS

   8.5. ONLINE PHARMACY

9. DRUG DELIVERY DEVICES MARKET, BY GEOGRAPHY

   9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

         9.1.1. NORTH AMERICA

                 9.1.1.1. U.S.

                 9.1.1.2. CANADA

                 9.1.1.3. MEXICO

         9.1.2. EUROPE

                 9.1.2.1. GERMANY

                 9.1.2.2. FRANCE

                 9.1.2.3. U.K.

                 9.1.2.4. ITALY

                 9.1.2.5. SPAIN

                 9.1.2.6. RUSSIA

                 9.1.2.7. TURKEY

                 9.1.2.8. BELGIUM

                 9.1.2.9. NETHERLANDS

                 9.1.2.10. SWITZERLAND

                 9.1.2.11. REST OF EUROPE

         9.1.3. ASIA-PACIFIC (APAC)

                 9.1.3.1. JAPAN

                 9.1.3.2. CHINA

                 9.1.3.3. SOUTH KOREA

                 9.1.3.4. INDIA

                 9.1.3.5. AUSTRALIA

                 9.1.3.6. SINGAPORE

                 9.1.3.7. THAILAND

                 9.1.3.8. MALAYSIA

                 9.1.3.9. INDONESIA

                 9.1.3.10. PHILIPPINES

                 9.1.3.11. REST OF APAC

         9.1.4. LATIN AMERICA

                 9.1.4.1. BRAZIL

                 9.1.4.2. REST OF LATIN AMERICA

         9.1.5. MIDDLE EAST AND AFRICA

                 9.1.5.1. SOUTH AFRICA

                 9.1.5.2. REST OF MIDDLE EAST AND AFRICA

     9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. DRUG DELIVERY DEVICES MARKET: COMPETITIVE LANDSCAPE

     10.1. GLOBAL DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS

     10.2. U.S. DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS

     10.3. EUROPE DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS

     10.4. APAC DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS

11. DRUG DELIVERY DEVICES MARKET, COMPANY PROFILES

     11.1. BAYER AG

            11.1.1. COMPANY OVERVIEW

            11.1.2  REVENUE ANALYSIS

            11.1.3  PRODUCT PORTFOLIO

            11.1.4  RECENT DEVELOPEMENTS

            11.1.5  DATA BRIDGE ANALYSIS

     11.2 JOHNSON & JOHNSON

            11.2.1  COMPANY OVERVIEW

            11.2.2  REVENUE ANALYSIS

            11.2.3  PRODUCT PORTFOLIO

            11.2.4  RECENT DEVELOPEMENTS

            11.2.5  DATA BRIDGE ANALYSIS

     11.3 NOVARTIS AG

            11.3.1  COMPANY OVERVIEW

            11.3.2  REVENUE ANALYSIS

            11.3.3  PRODUCT PORTFOLIO

            11.3.4  RECENT DEVELOPEMENTS

            11.3.5  DATA BRIDGE ANALYSIS

     11.4 PFIZER, INC.

            11.4.1  COMPANY OVERVIEW

            11.4.2  REVENUE ANALYSIS

            11.4.3  PRODUCT PORTFOLIO

            11.4.4  RECENT DEVELOPEMENTS

            11.4.5  DATA BRIDGE ANALYSIS

     11.5 F. HOFFMANN-LA ROCHE AG

           11.5.1  COMPANY OVERVIEW

           11.5.2  REVENUE ANALYSIS

           11.5.3  PRODUCT PORTFOLIO

           11.5.4  RECENT DEVELOPEMENTS

           11.5.5  DATA BRIDGE ANALYSIS

     11.6 GLAXOSMITHKLINE PLC

            11.6.1 COMPANY OVERVIEW

            11.6.2 REVENUE ANALYSIS

            11.6.3 PRODUCT PORTFOLIO

            11.6.4 RECENT DEVELOPEMENTS

            11.6.5 DATA BRIDGE ANALYSIS

     11.7 MERCK & CO.

           11.7.1 COMPANY OVERVIEW

           11.7.2 REVENUE ANALYSIS

           11.7.3 PRODUCT PORTFOLIO

           11.7.4 RECENT DEVELOPEMENTS

           11.7.5 DATA BRIDGE ANALYSIS

     11.8 ANTARES PHARMA, INC.

           11.8.1 COMPANY OVERVIEW

           11.8.2 REVENUE ANALYSIS

           11.8.3 PRODUCT PORTFOLIO

           11.8.4 RECENT DEVELOPEMENTS

           11.8.5 DATA BRIDGE ANALYSIS

     11.9 3M

            11.9.1 COMPANY OVERVIEW

            11.9.2 REVENUE ANALYSIS

            11.9.3 PRODUCT PORTFOLIO

            11.9.4 RECENT DEVELOPEMENTS

            11.9.5 DATA BRIDGE ANALYSIS

     11.10 SANOFI

             11.10.1 COMPANY OVERVIEW

             11.10.2 REVENUE ANALYSIS

             11.10.3 PRODUCT PORTFOLIO

             11.10.4 RECENT DEVELOPEMENTS

             11.10.5 DATA BRIDGE ANALYSIS

     11.11 NEMERA

             11.11.1 COMPANY OVERVIEW

             11.11.2 REVENUE ANALYSIS

             11.11.3 PRODUCT PORTFOLIO

             11.11.4 RECENT DEVELOPEMENTS

             11.11.5 DATA BRIDGE ANALYSIS

12. APPENDIX

13. DISCLAIMER

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Reports:

Global Self-Injections Market -Trends and Forecast to 2022

By Product (Devices (Needle-Free Injectors, Auto Injectors, Pen Injectors, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), By Route Of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), By End-User (Patient, Physicians, Home Care Settings, Others), By Distribution Channel (Hospital Pharmacies, Private Clinics, Chemist, Online Pharmacies), By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, South America, Rest Of The World) – Trends and Forecast to 2022

Global Injectable Drug Delivery Market – Trends and Forecast to 2022

By Type (Devices (Conventional Injection Devices, Self Injection Devices),  Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/